Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2008
11/19/2008EP1992695A2 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
11/19/2008EP1992694A1 Anti-tumor drug, medicament, composition, and use thereof
11/19/2008EP1992692A1 Immunoglobulin affinity ligand
11/19/2008EP1992691A1 New TTV sequences for diagnosis, prevention and treatment of childhood leukaemia
11/19/2008EP1992686A1 OXA1P enhanced protein secretion
11/19/2008EP1992642A1 Collagen fibrils carrying bioactive heterologous domains and their use in e.g. wound healing
11/19/2008EP1992641A2 GLP-1 analogues
11/19/2008EP1992640A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
11/19/2008EP1992639A1 Peptide vaccine for inducing production of anti-amyloid- -peptide antibody
11/19/2008EP1992638A1 Immunomodulatory and anti-tumour peptides
11/19/2008EP1992636A2 Process for correction of a disulfide misfold in Fc molecules
11/19/2008EP1992633A1 VEGI, an inhibitor of angiogenesis and tumor growth
11/19/2008EP1992352A1 Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function
11/19/2008EP1991693A1 Method for differentiating between multiple sclerosis subtypes
11/19/2008EP1991689A1 Process for the production of a fine chemical
11/19/2008EP1991685A2 Compositions and methods for increasing plant tolerance to high population density
11/19/2008EP1991683A1 Plants having increased yield and a method for making the same
11/19/2008EP1991681A1 Disease resistant plants
11/19/2008EP1991680A2 System for the expression of orthogonal translation components in eubacterial host cells
11/19/2008EP1991679A2 Human interferon-gamma (ifngamma) variants
11/19/2008EP1991584A1 Antibodies against human il-22 and uses therefor
11/19/2008EP1991578A2 Molecules and methods of using same for treating ccr5/ccr5 ligands associated diseases
11/19/2008EP1991577A2 Modulation of mdl-1 activity for treatment of inflammatory disease
11/19/2008EP1991576A1 Insulin derivatives
11/19/2008EP1991575A1 Single-chain insulin analogues and pharmaceutical formulations thereof
11/19/2008EP1991574A2 Oxyntomodulin derivatives
11/19/2008EP1991573A2 Peptides with properties of an allosteric antagonist selective for the alpha 1a adrenergic receptor and uses thereof
11/19/2008EP1991572A2 Peptides that block the binding of igg to fcrn
11/19/2008EP1991571A2 Antiviral agents and vaccines against influenza
11/19/2008EP1991570A1 Ammonia transporter gene and use thereof
11/19/2008EP1991569A2 Natively glycosylated mammalian biological molecules produced by eletromagnetically stimulating living mammalian cells
11/19/2008EP1991568A2 Genes for enhancing nitrogen utilization efficiency in crop plants
11/19/2008EP1991567A2 Polynucleotide encoding a maize herbicide resistance gene and methods for use
11/19/2008EP1991566A1 Gene encoding protein responsible for flocculation property of yeast and use thereof
11/19/2008EP1991565A2 Shiga toxoid chimeric proteins
11/19/2008EP1991564A2 Virosome-like vesicles comprising gp41-derived antigens
11/19/2008EP1991563A2 Peptide sequences and compositions
11/19/2008EP1991259A2 Viral display vehicles for treating multiple sclerosis
11/19/2008EP1991256A2 Clotting and healing compositions containing keratin biomaterials
11/19/2008EP1991255A1 Coagulation factor x polypeptides with modified activation properties
11/19/2008EP1991254A2 Broad spectrum immune and antiviral gene modulation by oral interferon
11/19/2008EP1991246A2 Treatment of development-related disorders
11/19/2008EP1991216A1 Means and methods for influencing interactions between dc-sign and dc-sign ligands
11/19/2008EP1791863A4 Truncated lhrh formulations
11/19/2008EP1706721A4 Bacillus licheniformis chromosome
11/19/2008EP1692156A4 Self-assembling split-fluorescent protein systems
11/19/2008EP1545607B1 Allergy vaccines
11/19/2008EP1472288B1 Viral cd30 polypeptide
11/19/2008EP1432990B1 Diabetic model
11/19/2008EP1428870B1 Reduction in the virulence of mycobacterium tuberculosis and protection against tuberculosis by means of phop gene inactivation
11/19/2008EP1377667B1 Fusion proteins for specific treatment of cancer and auto-immune diseases
11/19/2008EP1373510B1 Mutant allergens
11/19/2008EP1358213B1 Humanized antibodies that recognize beta amyloid peptide
11/19/2008EP1330475B1 Neuromedin u delta polypeptides
11/19/2008EP1301146A4 Artificial vascular grafts, and methods of producing and using same
11/19/2008EP1294910B1 Protein glycosylation modification in pichia pastoris
11/19/2008EP1268775B1 The high bone mass gene of 11q13.3
11/19/2008EP1171455B1 Polypeptide-k obtained from momordica charantia and a process for the extraction thereof
11/19/2008EP1132400B1 Novel protein, gene encoding the same and method of utilization thereof
11/19/2008EP1102528B1 Translation control elements for high-level protein expression in the plastids of higher plants and methods of use thereof
11/19/2008EP0983512B1 Method for identifying compounds binding to the chaperonin CCT
11/19/2008EP0949335B2 Process for preparing purified dimer of bone-derived factor
11/19/2008EP0888120B1 Immunogenic hla binding peptide and its uses to treat hiv infection
11/19/2008EP0745122B1 Galanin receptor, nucleic acids, transformed cells and uses thereof
11/19/2008CN101310020A Methods for genetic control of insect infestations in plantsand compositions thereof
11/19/2008CN101310016A Glucoamylase variants
11/19/2008CN101309934A 修饰的伴侣蛋白10 Modified chaperonin 10
11/19/2008CN101309932A Novel mucin glycoprotein and use thereof
11/19/2008CN101309931A Vaccines comprising truncated HBC core protein plus saponin-based adjuvants
11/19/2008CN101309930A Splice variants of erbb ligands, compositions and uses thereof
11/19/2008CN101309705A Preventive or therapeutic agent and method for immune disease
11/19/2008CN101309699A Stabilized virus-like particles and epitope display systems
11/19/2008CN101307317A Method for preparing rabies virus antigen
11/19/2008CN101307316A Secretion expression of antibiotic peptide CAD in bacillus subtilis and expression system of recombination bacillus subtilis
11/19/2008CN101307315A Method for expressing growth factor of human blood vessel in bombyx mori by Bac-to-Bac system
11/19/2008CN101307313A Disinsection fungal engineering strain inverted from scorpion toxin gene and applications
11/19/2008CN101307312A Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
11/19/2008CN101307310A Expression system with recombination protein for increasing yield and immunogenicity
11/19/2008CN101307107A Protein tau
11/19/2008CN101307106A Endothelial cell proliferation inhibitor and method of use
11/19/2008CN101307105A Human parathyroid hormone 1-34 peptide analogue capable of expressing in series and being released by synchronousacid hydrolysis, preparation method thereof and use
11/19/2008CN101307104A Recombination escherichia coli with Z9CCK protein, yolk antibody and applications
11/19/2008CN101307103A Purification method of follicle stimulating hormone
11/19/2008CN101307102A Human hypoxia inducible factor-1 alpha recombinant adenovirus carrier and uses thereof
11/19/2008CN101307101A Novel modification-specific signal Conus superfamily toxin and uses thereof
11/19/2008CN101307100A Polypeptide fragments of antibiotic peptide, nucleotide sequence thereof and applications
11/19/2008CN101307099A Protein related to iron deficiency resistance of plants, encoding gene thereof and use
11/19/2008CN101307098A Preparation method of enhancing peptide fragment immunocompetence and use
11/19/2008CN101307097A Preparation method of enhancing peptide fragment immunocompetence and use
11/19/2008CN101307096A Preparation method of enhancing peptide fragment immunocompetence and use
11/19/2008CN101307095A T-cell epitope peptide
11/19/2008CN101307092A Method for synthesizing general artificial antigen of beta-lactam drugs
11/19/2008CN100434439C Genes and polypeptides relating to chronic myeloid leukemia
11/19/2008CN100434438C Preparation method of CYP1A2 polypeptide and antihuman CYP1A2 polypeptide antibody
11/18/2008US7453028 Soybean cultivar S060077
11/18/2008US7452983 Protein which binds to Akt2
11/18/2008US7452982 An immunogenic complex characterised in that an enzyme is integrated into an immunostimulating complex (ISCOM) containing a glycoside, a lipid and an antigen
11/18/2008US7452980 Compositions and methods for the diagnosis and treatment of immune disorders
11/18/2008US7452975 Induction of chrondrocyte proliferation/differentiation; antitumor agents; antiinflammatory agents; antiproliferative agents; anticarcinogenic agents; antisense agents; cancer diagnosis
11/18/2008US7452974 Drug targets related to synthase subfamily; alternative splice forms; isolated peptides and antibodies
1 ... 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 ... 2916